[ET Net News Agency, 30 November 2020] Sino Biopharmaceutical Limited (01177) said for
the nine months ended 30 September 2020, profit attributable to the owners of the parent
was RMB1,850.5 million, 18% lower than that of the same period last year. Basic earnings
per share were RMB9.81. A quarterly dividend of HK2 cents per share will be distributed.
Revenue was RMB18,125.79 million, a decrease of 6.2% over the same period last year.
(RC)